Standards of specialized diabetes care

Diabetes Mellitus

Volumn 20, Issue 1S, 2017, Pages 1-112

  Dedov, Ivan I ^a   Shestakova, Marina V ^a   Mayorov, Aleksandr Y ^a   Vikulova, Olga K ^c   Galstyan, Gagik R ^a   Kuraeva, Tamara L ^a   Peterkova, Valentina A ^a   Smirnova, Olga M ^a   Starostina, Elena G ^b   Surkova, Elena V ^a   Sukhareva, Olga Y ^a   Tokmakova, Alla Y ^a   Shamkhalova, Minara S ^a   Jarek Martynova, Ivona Renata ^a   Beshlieva, Diana D ^a   Bondarenko, Olga N ^a   Volevodz, Natalya N ^a   Grigoryan, Olga R ^a   Esayan, Roza M ^c   Ibragimova, Liudmila I ^a   Kalashnikov, Viktor Y ^a   Lipatov, Dmitry V ^a   Shestakova, Ekaterina A ^a   more..

^a ENDOCRINOLOGY RESEARCH CENTRE   (Russian Federation)

^b M F VLADIMIRSKY MOSCOW REGIONAL RESEARCH CLINICAL INSTITUTE   (Russian Federation)

^c RESEARCH CENTER OF OBSTETRICS   (Russian Federation)

Author keywords

Algoritms; Diabetes mellitus; Diagnosis; Guidelines; Prevention; Standards; Treatment

Indexed keywords

ARTICLE; BLOOD PRESSURE; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; DECISION MAKING; DISABILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; LIMIT OF QUANTITATION; MORBID OBESITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; RETINOPATHY; RUSSIAN FEDERATION;

EID: 85020453747     PISSN: 20720351     EISSN: 20720378     Source Type: Journal    
DOI: 10.14341/DM20171S8     Document Type: Article

References (41)

1. Dedov I, Krasnopol'skiy V, Sukhikh G. Russian National Consensus Statement on gestational diabetes: diagnostics, treatment and postnatal care. Diabetes mellitus. - 2012. - T.15. - No4. - C.4-10.] doi: 10.14341/2072-0351-5531.
2. Dedov I, Peterkova V, Kuraeva T. Rossiyskiy konsensus po terapii sakharnogo diabeta u detey i podrostkov. Diabetes mellitus. 2010;13(5):1-8.] doi: 10.14341/2072-0351-6048.
3. Dedov II, Shestakova MV, Aleksandrov AA, et al. Algorithms of Specialized Medical Care for Diabetes Mellitus Patients. Edited by Dedov II, Shestakova MV (5th edition). Diabetes mellitus. 2011;14(3s):2-72.] doi: 10.14341/2072-0351-5612.
4. Dedov I, Shestakova M, Ametov A, et al. Initiation and intensification of antihyperglycemic therapy in type 2 diabetes mellitus: Update of Russian Association of Endocrinologists expert consensus document (2015). Diabetes mellitus. 2015;18(1):4-22.] doi: 10.14341/DM201515-23.
5. Dedov II, Shestakova MV, Aleksandrov AA, et al. Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV. (6th edition). Diabetes mellitus. 2013;16(1S):1-121.] doi: 10.14341/DM20131S1-121.
6. Dedov I, Shestakova M, Ametov A, et al. Russian Association of Endocrinologists expert consensus document on initiation and intensification of antyhiperglycaemic therapy in type 2 diabetes mellitus. Diabetes mellitus. 2011;14(4):6-17.] doi: 10.14341/2072-0351-5810.
7. Dedov II, Shestakova MV, Vikulova OK, et al. Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV (7th edition). Diabetes mellitus. 2015;18(1S):1-112.] doi: 10.14341/DM20151S1-112.
8. Dedov I, Shestakova M, et al. Optimizatsiya i intensifikatsiya insulinoterapii pri sakharnom diabete 2 tipa (klinicheskie rekomendatsii). Diabetes mellitus. 2010;13(5):9-16.] doi: 10.14341/2072-0351-6049.
9. Belenkov YN, Oganov RG, eds. Klinicheskie rekomendatsii. Kardiologiya. Moscow: GEOTAR-Media; 2007. 640p.
10. Dedov II, Shestakova MV, eds. Complications of diabetes mellitus: treatment and prevention. Moscow: Meditsinskoe informatsionnoe agentstvo; 2017.
11. Potemkin VV, Starostina EG. Rukovodstvo po neotlozhnoy endokrinologii. Moscow: Meditsinskoe informatsionnoe agentstvo; 2008. 393p.
12. Rekomendatsii po lecheniyu ostrogo koronarnogo sindroma bez stoykogo pod'ema segmenta ST na EKG. Russian guidelines. Moscow; 2008. www.cadriosite.ru.
13. Dedov II, Shestakova MV, eds. Diabetes mellitus Type 1: reality and perspectives. Moscow: Meditsinskoe informatsionnoe agentstvo; 2016.
14. Dedov II, Shestakova MV, eds. Diabetes mellitus Type 2: from theory to practice. Moscow: Meditsinskoe informatsionnoe agentstvo; 2016.
15. Dedov II, Shestakova MV, eds. Diabetes mellitus: heterogenity of clinical forms. Moscow: Meditsinskoe informatsionnoe agentstvo; 2016.
16. Dedov II, Shestakova MV, eds. Diabetes mellitus and reproductive system. Moscow: Meditsinskoe informatsionnoe agentstvo; 2016.
17. Shestakova MV, Dedov II. Diabetes mellitus and chronic kidney disease. Moscow: Meditsinskoe informatsionnoe agentstvo; 2009. 500p.
18. American Diabetes Association. Standards of medical care in diabetes - 2017. Diabetes Care 2017; 40; Suppl 1:S1-135.
19. Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28(13):1598-1660. doi: 10.1093/eurheartj/ehm161.
20. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of WHO/IDF Consultation. 2006.
21. Definition, Diagnosis, and Classification of Diabetes Mellitus and Its Complications: Report of a WHO consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus (WHO/NCD/NCS/99.2). Geneva: World Health Organization; 1999.
22. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. WHO Guideline. 2013.
23. Frid AH, Kreugel G, Grassi G, et al. New Insulin Delivery Recommendations. Mayo Clin Proc. 2016;91(9):1231-1255. doi: 10.1016/j.mayocp.2016.06.010.
24. Garber AJ, Abrahamson MJ, Barzilay JI, et al. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm - 2017 Executive Summary. Endocr Pract. 2017;23(2):207-238. doi: 10.4158/EP161682.CS.
25. International Diabetes Federation. Diabetes Atlas 7th Edition. 2015.
26. International Diabetes Federation. Global Guideline for Type 2 diabetes. 2012.
27. International Diabetes Federation. Guideline for management of postmeal glucose. 2011.
28. International Diabetes Federation. Managing older people with Type 2 Diabetes. Global Guideline. 2013.
29. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38(1):140-149. doi: 10.2337/dc14-2441.
30. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364-1379. doi: 10.2337/dc12-0413.
31. ISPAD Clinical Practice Consensus Guidelines 2014 Compendium. Pediatric Diabetes. 2014; 15(Suppl. 20): 1-290.
32. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Intern. Suppl. 2013; 3(1):1-150.
33. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281-1357. doi: 10.1097/01.hjh.0000431740.32696.cc.
34. Marso SP, Daniels GH, Brown-Frandsen K, et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016;375(4):311-322. doi: 10.1056/NEJMoa1603827.
35. Group AC, Patel A, MacMahon S, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560-2572. doi: 10.1056/NEJMoa0802987.
36. Pfeffer MA, Claggett B, Diaz R, et al. Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome. N Engl J Med. 2015;373(23):2247-2257. doi: 10.1056/NEJMoa1509225.
37. Ryden L, Grant PJ, Anker SD, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34(39):3035-3087. doi: 10.1093/eurheartj/eht108.
38. Skyler JS, Bergenstal R, Bonow RO, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care. 2009;32(1):187-192. doi: 10.2337/dc08-9026.
39. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. Abbreviated Report of a WHO Consultation (WHO/NMH/CHP/CPM/11.1). World Health Organization; 2011.
40. Wright RS, Anderson JL, Adams CD, et al. 2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;57(19):1920-1959. doi: 10.1016/j.jacc.2011.02.009.
41. Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med. 2015;373(22):2117-2128. doi: 10.1056/NEJMoa1504720.